【医药】首项脑机接口医疗器械行业标准落地，建议关注脑机接口相关标的——医药行业跨市场周报（20250921）（王明瑞/黎一江）

Market Overview - The A-share pharmaceutical and biotechnology index fell by 0.67%, underperforming the CSI 300 index by 0.23 percentage points and the ChiNext index by 1.97 percentage points, ranking 18th among 31 sub-industries [4] - The H-share Hang Seng Healthcare Index dropped by 1.95%, underperforming the Hang Seng Index by 3.1 percentage points [4] Key Insights - The first industry standard for brain-computer interface (BCI) medical devices has been established, suggesting a focus on BCI-related stocks. On September 15, the National Medical Products Administration (NMPA) officially released the YY/T 1987—2025 standard, which constructs a terminology system for BCI medical devices, clarifying core terms and definitions [5] - The implementation of this standard addresses fundamental challenges in the industry, providing a unified technical language and key technical basis for the research, production, and scientific regulation of BCI medical devices, marking a significant step for high-quality development in the sector [5] Global Initiatives - Various global brain initiatives have been launched over the years. The U.S. launched its Brain Initiative in 2013, led by the National Institutes of Health, focusing on brain structure, neural recording, and neuroethics [6] - The European Union initiated the Human Brain Project (HBP) in 2013 with a total investment of €1 billion over ten years [6] - On July 23, 2025, multiple Chinese governmental departments released implementation opinions to promote innovation and development in the BCI industry, providing comprehensive support for industry growth [6]